Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Shareholder's Equity

v3.23.2
Condensed Consolidated Statement of Shareholder's Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Pre Paid Advance Agreement
Securities Purchase Agreement
PIPE
Sale Of Shares Under The Wainwright ATM Program
Standby Equity Purchase Agreement
VDL Nedcar
Common stock
Common stock
Pre Paid Advance Agreement
Common stock
PIPE
Common stock
Sale Of Shares Under The Wainwright ATM Program
Common stock
Standby Equity Purchase Agreement
Common stock
VDL Nedcar
Additional paid-in capital
Additional paid-in capital
Pre Paid Advance Agreement
Additional paid-in capital
Securities Purchase Agreement
Additional paid-in capital
PIPE
Additional paid-in capital
Sale Of Shares Under The Wainwright ATM Program
Additional paid-in capital
Standby Equity Purchase Agreement
Additional paid-in capital
VDL Nedcar
Accumulated deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2021               238,578                          
Balance as of beginning of period at Dec. 31, 2021 $ 343,999             $ 24           $ 1,036,104             $ (692,129)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Repurchase of unvested shares - forfeitures (shares)               (296)                          
Repurchase of unvested shares – forfeitures (3)                         (3)              
Issuance of shares for restricted stock units vested (in shares)               584                          
Issuance of shares for restricted stock units vested 0                                        
Issuance of shares upon exercise of vested stock options (in shares)               20                          
Issuance of shares upon exercise of vested stock options 0                                        
Issuance of shares under the PPA , SPA, SEPA and PIPE (in shares)                         972                
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE             $ 8,400                         $ 8,400  
Stock-based compensation 20,680                         20,680              
Net loss and comprehensive loss (125,367)                                       (125,367)
Net loss and comprehensive loss (125,367)                                       (125,367)
Balance at the end of the period (in shares) at Mar. 31, 2022               239,858                          
Balance as of end of period at Mar. 31, 2022 247,709             $ 24           1,065,181             (817,496)
Balance at the beginning of the period (in shares) at Dec. 31, 2021               238,578                          
Balance as of beginning of period at Dec. 31, 2021 343,999             $ 24           1,036,104             (692,129)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Reclassification of warrant liability to additional paid-in capital 0                                        
Net loss and comprehensive loss (289,757)                                        
Net loss and comprehensive loss (289,757)                                        
Balance at the end of the period (in shares) at Jun. 30, 2022               268,896                          
Balance as of end of period at Jun. 30, 2022 188,345             $ 26           1,170,207             (981,888)
Balance at the beginning of the period (in shares) at Mar. 31, 2022               239,858                          
Balance as of beginning of period at Mar. 31, 2022 247,709             $ 24           1,065,181             (817,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Repurchase of unvested shares - forfeitures (shares)               (175)                          
Repurchase of unvested shares – forfeitures (3)                         (3)              
Issuance of shares for restricted stock units vested (in shares)               1,017                          
Issuance of shares for restricted stock units vested 0                                        
Issuance of shares upon exercise of vested stock options (in shares)               7                          
Issuance of shares upon exercise of vested stock options 0                                       0
Issuance of shares under employee stock purchase plan (in shares)               254                          
Issuance of shares under employee stock purchase plan 1,175                         1,175              
Issuance of shares under the PPA , SPA, SEPA and PIPE (in shares)                   13,699   14,236                  
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE       $ 50,000   $ 33,083       $ 1   $ 1         $ 49,999   $ 33,082    
Stock-based compensation 20,773                         20,773              
Net loss and comprehensive loss (164,392)                                       (164,392)
Net loss and comprehensive loss (164,392)                                       (164,392)
Balance at the end of the period (in shares) at Jun. 30, 2022               268,896                          
Balance as of end of period at Jun. 30, 2022 $ 188,345             $ 26           1,170,207             (981,888)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Common stock, shares issued (in shares) 355,388                                        
Balance at the beginning of the period (in shares) at Dec. 31, 2022 355,388             355,388                          
Balance as of beginning of period at Dec. 31, 2022 $ 236,573             $ 35           1,416,361             (1,179,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Repurchase of unvested shares - forfeitures (shares)               (22)                          
Repurchase of unvested shares – forfeitures 0                         0              
Issuance of shares for restricted stock units vested (in shares)               2,768                          
Issuance of shares for restricted stock units vested 0                                        
Issuance of shares upon exercise of vested stock options (in shares)               2                          
Issuance of shares upon exercise of vested stock options 0                                        
Issuance of shares under employee stock purchase plan (in shares)               701                          
Issuance of shares under employee stock purchase plan 389                         389              
Vesting of early exercised stock options and restricted stock awards 26                         26              
Issuance of shares under the PPA , SPA, SEPA and PIPE (in shares)               50,000 66,761                        
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE 10,161 $ 64,389 $ 1,600         $ 5 $ 7         10,156 $ 64,382 $ 1,600          
Reclassification of warrant liability to additional paid-in capital 19,510                         19,510              
Stock-based compensation 9,836                         9,836              
Net loss and comprehensive loss (90,732)                                       (90,732)
Net loss and comprehensive loss (90,732)                                       (90,732)
Balance at the end of the period (in shares) at Mar. 31, 2023               475,598                          
Balance as of end of period at Mar. 31, 2023 $ 251,752             $ 47           1,522,260             (1,270,555)
Balance at the beginning of the period (in shares) at Dec. 31, 2022 355,388             355,388                          
Balance as of beginning of period at Dec. 31, 2022 $ 236,573             $ 35           1,416,361             (1,179,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE     $ 1,600                                    
Reclassification of warrant liability to additional paid-in capital 19,510                                        
Net loss and comprehensive loss (161,602)                                        
Net loss and comprehensive loss $ (161,602)                                        
Balance at the end of the period (in shares) at Jun. 30, 2023 568,904             568,904                          
Balance as of end of period at Jun. 30, 2023 $ 232,745             $ 56           1,574,114             (1,341,425)
Balance at the beginning of the period (in shares) at Mar. 31, 2023               475,598                          
Balance as of beginning of period at Mar. 31, 2023 251,752             $ 47           1,522,260             (1,270,555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Repurchase of unvested shares - forfeitures (shares)               (27)                          
Repurchase of unvested shares – forfeitures 0                         0              
Issuance of shares for restricted stock units vested (in shares)               2,028                          
Issuance of shares for restricted stock units vested 0                                        
Issuance of shares upon exercise of vested stock options (in shares)               2                          
Issuance of shares upon exercise of vested stock options 0                                        
Issuance of shares under employee stock purchase plan (in shares)               604                          
Issuance of shares under employee stock purchase plan 246                         246              
Vesting of early exercised stock options and restricted stock awards 2                         2              
Issuance of shares under the PPA , SPA, SEPA and PIPE (in shares)                   16,331 1,911                    
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE       $ 1,753 $ 1,155         $ 2             $ 1,751 $ 1,155      
Stock-based compensation 6,707                         6,707              
Net loss and comprehensive loss (70,870)                                       (70,870)
Net loss and comprehensive loss (70,870)                                       (70,870)
Proceeds from exercise of YA warrants (in shares)               34,231                          
Proceeds from exercise of YA warrants 21,223             $ 3           21,220              
Issuance of shares under YA convertible debenture (in shares)               35,699                          
Issuance of shares under YA convertible debenture 19,021             $ 4           19,017              
Issuance of shares under I-40 financing arrangement (in shares)               2,320                          
Issuance of shares under I-40 financing arrangement 1,506                         1,506              
Issuance of shares to vendor for services (in shares)               207                          
Issuance of shares to vendor for services $ 250                         250              
Balance at the end of the period (in shares) at Jun. 30, 2023 568,904             568,904                          
Balance as of end of period at Jun. 30, 2023 $ 232,745             $ 56           $ 1,574,114             $ (1,341,425)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Common stock, shares issued (in shares) 568,904